Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equine Anti-Tetanus F(ab')2 for short-term tetanus prophylaxis
CTR20140549Phase 3Completed
- Sponsor
- Yuxi Jiuzhou Biotechnology
- Start
- Mar 2019
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of equine tetanus immunoglobulin in Tetanus, sponsored by Yuxi Jiuzhou Biotechnology. Started Mar 2019; status: completed.
02
Drugs
equine tetanus immunoglobulin
03
Conditions
Tetanus
Beyond the preview
Go deeper on CTR20140549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140549.